(Q36392370)

13 August 2017

Remission by composite scores in rheumatoid arthritis: are ankles and feet important? (English)

1 reference

13 August 2017

1 reference

6

Josef S Smolen

1 reference

13 August 2017

7

Daniel Aletaha

1 reference

13 August 2017

3

Klaus P Machold

1 reference

13 August 2017

4

Tanja Stamm

1 reference

13 August 2017

5

Monika Schoels

1 reference

13 August 2017

1

Theresa Kapral

1 reference

13 August 2017

Florian Dernoschnig

2

1 reference

13 August 2017

1 January 2007

1 reference

Arthritis Research and Therapy

13 August 2017

1 reference

13 August 2017

9

1 reference

13 August 2017

R72

1 reference

13 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1186/ar2270

13 August 2017

0 references

cites work

The definition and measurement of disease modification in inflammatory rheumatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

Early rheumatoid arthritis: time to aim for remission?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

Quantitative measures to assess, monitor and predict morbidity and mortality in rheumatoid arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206375

Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission

21 September 2018

1 reference

12 December 2020

Therapeutic strategies for rheumatoid arthritis

1 reference

12 December 2020

Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria

1 reference

12 December 2020

Measurement of patient outcome in arthritis

1 reference

12 December 2020

Clinical responses during gold therapy for rheumatoid arthritis. Changes in synovitis, radiologically detectable erosive lesions, serum proteins, and serologic abnormalities

1 reference

12 December 2020

Methods of X-ray assessment in rheumatoid arthritis: a re-evaluation

1 reference

12 December 2020

Reduced joint count indices in the evaluation of rheumatoid arthritis

1 reference

12 December 2020

Radiographic and joint count findings of the hand in rheumatoid arthritis. Related and unrelated findings

1 reference

12 December 2020

Reduced joint counts in controlled clinical trials in rheumatoid arthritis

1 reference

12 December 2020

Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity

1 reference

12 December 2020

Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: clinical evaluation and cost analysis

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR2270

1 reference

PMCID

2206375

Dimensions Publication ID

13 August 2017

0 references

1 reference

13 August 2017

1 reference

PMCID

2206375